Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001193125-25-326771

Chief Financial Officer gave up 145,007 shares (to pay taxes)

  • Chief Financial Officer acquired 350,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Green John L. · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-17 Grant or award : show line 1 in the form +50,000 53,841 D
2025-12-17 Grant or award : show line 2 in the form +300,000 353,841 D
2025-12-17 Shares withheld for taxes : show line 3 in the form −145,007 $39.45 $5,720,526 208,834 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-17 Grant or award : show line 4 in the form Stock Option (Right to Buy) +65,000 65,000 D
Loading xslF345X05/ownership.xml…